RELATED CONTENT
NEWS
- Conditional European approval for Fampyra for MS walking disability
- BMS' kidney transplant drug, Nulojix, granted European approval
- EU reprieve for Actos as CHMP concludes benefits outweigh risks in selected patients
- Merck Serono ditches cladribine, leaving MS franchise exposed

